Prelude Capital Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,111
| Closed | -$35.3K | – | 1214 |
|
|
2024
Q3 | $35.3K | Sell |
13,111
-7,117
| -35% | -$19.1K | ﹤0.01% | 1120 |
|
|
2024
Q2 | $57.7K | Buy |
20,228
+3,700
| +22% | +$10.5K | ﹤0.01% | 1046 |
|
|
2024
Q1 | $70.1K | Hold |
16,528
| – | – | ﹤0.01% | 1117 |
|
|
2023
Q4 | $88.4K | Sell |
16,528
-3,072
| -16% | -$16.4K | 0.01% | 908 |
|
|
2023
Q3 | $84.3K | Buy |
19,600
+7,100
| +57% | +$30.5K | 0.01% | 864 |
|
|
2023
Q2 | $68.6K | Buy |
+12,500
| New | +$68.6K | ﹤0.01% | 841 |
|
|
2018
Q1 | – | Sell |
-1,900
| Closed | -$6K | – | 1429 |
|
|
2017
Q4 | $6K | Buy |
+1,900
| New | +$6K | ﹤0.01% | 1114 |
|
|
2016
Q2 | – | Sell |
-15,100
| Closed | -$46K | – | 1570 |
|
|
2016
Q1 | $46K | Buy |
15,100
+4,900
| +48% | +$14.9K | 0.01% | 913 |
|
|
2015
Q4 | $35K | Buy |
10,200
+6,527
| +178% | +$22.4K | 0.01% | 1037 |
|
|
2015
Q3 | $14K | Buy |
+3,673
| New | +$14K | ﹤0.01% | 1208 |
|